US Patent 7183316 Treatment of HPV caused diseases
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+312 characters)
Article
Patent abstract
Human papillomavirus (HPV) protein expression is downregulated in patients infected with HPV by administration of PPARγ ligand, selective inhibitor of cyclooxygenase-2 (COX-2), diaryl heterocycle, inhibitor of HPV protein from a natural source and/or certain non-steroidal anti-inflammatory drugs.
Edits on 1 Aug, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
71833160
Date of Patent
February 27, 2007
0Patent Application Number
100968190
Date Filed
March 14, 2002
0Patent Primary Examiner
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07183316 Treatment of HPV caused diseases US Patent 7183316 Treatment of HPV caused diseases
Infobox
Patent Number
0718331600
Patent Number
718331600
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071833160
Date of Patent
February 27, 2007
0Patent Application Number
100968190
Date Filed
March 14, 2002
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071833160
Date of Patent
February 27, 2007
0Patent Application Number
100968190
Date Filed
March 14, 2002
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07183316 Treatment of HPV caused diseases
Infobox
Is a
Patent jurisdiction
Patent number
07183316
Date of patent
February 27, 2007
Patent application number
10096819
Date Filed
March 14, 2002
Patent primary examiner
Find more entities like US Patent 7183316 Treatment of HPV caused diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
